MaKe | Multiple MaHui Members Named to 2023 China Healthcare Industry Investment and Financing Glory List

Recently, CHC Healthcare Consulting and CITIC Securities jointly released the 2023 China Healthcare Industry Investment & Financing Glory Rankings. Based on a comprehensive review of investment and financing trends in the healthcare sector, the rankings evaluated candidates across multiple dimensions — institutional activity, number of investments, standout cases, investment returns, assets under management, corporate financing and growth trajectories, and valuations. Following a fair and transparent selection process, five categories comprising 15 awards were presented: investment institutions, enterprises, service providers, industrial parks, and individuals.

Yuhao Zhang, an investor at Source Code Capital, was named to the Top 15 Healthcare Glory Stars of the Year.

DeepWise and METiS Pharmaceuticals, both MaHui portfolio companies, were named to the Top 50 Most Investable Healthcare Enterprises of the Year.

The honored companies and individuals have distinguished themselves through excellence in technological innovation, market expansion, capital operations, professional services, and park development — earning greater room for growth and serving as inspiring examples of contributors who combine wisdom with rationality, and strength with courage, for China's healthcare industry.

Source Code Capital is an investment firm built on entrepreneurial spirit, committed to backing technology-driven innovation and the creation of enduring, real value. We look forward to walking alongside more founders — exploring without end, with our sights set on vast horizons.

The Top 15 Healthcare Glory Stars of the Year:

The Top 50 Most Investable Healthcare Enterprises of the Year: